BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 15580297)

  • 1. Sumoylation of the net inhibitory domain (NID) is stimulated by PIAS1 and has a negative effect on the transcriptional activity of Net.
    Wasylyk C; Criqui-Filipe P; Wasylyk B
    Oncogene; 2005 Jan; 24(5):820-8. PubMed ID: 15580297
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The transcriptional repression activity of KyoT2 on the Notch/RBP-J pathway is regulated by PIAS1-catalyzed SUMOylation.
    Wang J; Qin H; Liang J; Zhu Y; Liang L; Zheng M; Han H
    J Mol Biol; 2007 Jun; 370(1):27-38. PubMed ID: 17509614
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Net, a negative Ras-switchable TCF, contains a second inhibition domain, the CID, that mediates repression through interactions with CtBP and de-acetylation.
    Criqui-Filipe P; Ducret C; Maira SM; Wasylyk B
    EMBO J; 1999 Jun; 18(12):3392-403. PubMed ID: 10369679
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extracellular signal-regulated kinase 5 SUMOylation antagonizes shear stress-induced antiinflammatory response and endothelial nitric oxide synthase expression in endothelial cells.
    Woo CH; Shishido T; McClain C; Lim JH; Li JD; Yang J; Yan C; Abe J
    Circ Res; 2008 Mar; 102(5):538-45. PubMed ID: 18218985
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role for SUMO modification in facilitating transcriptional repression by BKLF.
    Perdomo J; Verger A; Turner J; Crossley M
    Mol Cell Biol; 2005 Feb; 25(4):1549-59. PubMed ID: 15684403
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PIAS1 interacts with and represses SOX9 transactivation activity.
    Oh HJ; Kido T; Lau YF
    Mol Reprod Dev; 2007 Nov; 74(11):1446-55. PubMed ID: 17440973
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Down-regulation of c-Fos/c-Jun AP-1 dimer activity by sumoylation.
    Bossis G; Malnou CE; Farras R; Andermarcher E; Hipskind R; Rodriguez M; Schmidt D; Muller S; Jariel-Encontre I; Piechaczyk M
    Mol Cell Biol; 2005 Aug; 25(16):6964-79. PubMed ID: 16055710
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sumoylation of the yeast Gcn5 protein.
    Sterner DE; Nathan D; Reindle A; Johnson ES; Berger SL
    Biochemistry; 2006 Jan; 45(3):1035-42. PubMed ID: 16411780
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sumoylation of Drosophila transcription factor STAT92E.
    Grönholm J; Ungureanu D; Vanhatupa S; Rämet M; Silvennoinen O
    J Innate Immun; 2010; 2(6):618-24. PubMed ID: 20616536
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sumoylation differentially regulates Goosecoid-mediated transcriptional repression.
    Izzi L; Narimatsu M; Attisano L
    Exp Cell Res; 2008 Apr; 314(7):1585-94. PubMed ID: 18336814
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liver receptor homolog-1 localization in the nuclear body is regulated by sumoylation and cAMP signaling in rat granulosa cells.
    Yang FM; Pan CT; Tsai HM; Chiu TW; Wu ML; Hu MC
    FEBS J; 2009 Jan; 276(2):425-36. PubMed ID: 19125815
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PIASxalpha differentially regulates the amplitudes of transcriptional responses following activation of the ERK and p38 MAPK pathways.
    Yang SH; Sharrocks AD
    Mol Cell; 2006 May; 22(4):477-87. PubMed ID: 16713578
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sumoylation of LIN-1 promotes transcriptional repression and inhibition of vulval cell fates.
    Leight ER; Glossip D; Kornfeld K
    Development; 2005 Mar; 132(5):1047-56. PubMed ID: 15689373
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SUMO modification modulates the transrepression activity of PLZF.
    Chao TT; Chang CC; Shih HM
    Biochem Biophys Res Commun; 2007 Jun; 358(2):475-82. PubMed ID: 17498654
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phospho-regulated SUMO interaction modules connect the SUMO system to CK2 signaling.
    Stehmeier P; Muller S
    Mol Cell; 2009 Feb; 33(3):400-9. PubMed ID: 19217413
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SUMOylation regulates nucleo-cytoplasmic shuttling of Elk-1.
    Salinas S; Briançon-Marjollet A; Bossis G; Lopez MA; Piechaczyk M; Jariel-Encontre I; Debant A; Hipskind RA
    J Cell Biol; 2004 Jun; 165(6):767-73. PubMed ID: 15210726
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of the SUMO pathway sensitizes differentiating human endometrial stromal cells to progesterone.
    Jones MC; Fusi L; Higham JH; Abdel-Hafiz H; Horwitz KB; Lam EW; Brosens JJ
    Proc Natl Acad Sci U S A; 2006 Oct; 103(44):16272-7. PubMed ID: 17053081
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protein inhibitor of activated signal transducer and activator of transcription 1 interacts with the N-terminal domain of mineralocorticoid receptor and represses its transcriptional activity: implication of small ubiquitin-related modifier 1 modification.
    Tallec LP; Kirsh O; Lecomte MC; Viengchareun S; Zennaro MC; Dejean A; Lombès M
    Mol Endocrinol; 2003 Dec; 17(12):2529-42. PubMed ID: 14500761
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SUMOylation can regulate the activity of ETS-like transcription factor 4.
    Kaikkonen S; Makkonen H; Rytinki M; Palvimo JJ
    Biochim Biophys Acta; 2010 Aug; 1799(8):555-60. PubMed ID: 20637912
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of transcription factor activity by SUMO modification.
    Ouyang J; Valin A; Gill G
    Methods Mol Biol; 2009; 497():141-52. PubMed ID: 19107415
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.